November 13, 2024Journal of clinical lipidology37 citationsOpen Access
View Full PaperDevelopment and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America
Structured PICO
Does the NAFCS Score accurately distinguish patients with FCS from MCS?
P
Population
Patients in North America being evaluated for familial chylomicronemia syndrome (FCS) or multifactorial chylomicronemia syndrome (MCS)
I
Intervention
NAFCS Score (clinical criteria)
O
Outcome
Distinguishing patients with FCS from MCS
The NAFCS Score provides a simple, highly specific clinical tool to identify familial chylomicronemia syndrome, potentially reducing the immediate need for genetic testing.
Abstract
Given its simplicity and high specificity for distinguishing patients with FCS from MCS, the NAFCS Score could be used in lieu of - or while awaiting - genetic testing to optimize treatment.